
Judge rejects auditor general's bid to access Vitalité's internal audits on travel nurses
A New Brunswick judge has rejected the auditor general's bid to access Vitalité Health Network's internal audits of its controversial travel-nurse contracts.
Auditor General Paul Martin sought a court order to compel the regional health authority to disclose the documents as part of his investigation into the management and use of private agency nurses by Vitalité, Horizon and the Department of Social Development between Jan. 1, 2022, and Feb. 29, 2024.
But Court of King's Bench Chief Justice Tracey DeWare dismissed his application, saying she's not satisfied the Auditor General Act provides an explicit waiver of Vitalité's claims of litigation privilege or solicitor-client privilege.
These privileges are "foundational to our legal system," DeWare wrote in her decision, dated June 2.
"The Court can only endorse a legislative interpretation which abrogates these privileges in circumstances where the intention of the Legislature can be clearly discerned to have contemplated the scope of such an exceptional authority."
Vitalité is entitled to costs of $2,000, she ruled.
CBC News requested an interview with Martin, including whether he intends to appeal. In response, his office sent an emailed statement, saying he received notice of the dismissal last week and is "currently assessing the next steps."
Vitalité did not immediately respond to a request for comment.
In a scathing report last June, Martin concluded Vitalité spent $123 million in travel-nurse contracts dating back to 2022, when the regional health authority signed its first deal with Canadian Health Labs. The Ontario-based agency charged about $300 an hour per nurse — roughly six times what a local staff nurse earns.
"The contracts with private nursing agencies were not reflective of best practices and did not demonstrate value for money," Martin said at the time.
As part of that audit, launched in March 2024, Martin requested "various information and documents" from Vitalité, including internal audit reports on the use of agency nurses.
Internal audits were to probe 'irregularities'
Vitalité refused to provide the internal audit reports. It had commissioned the audits after it "noticed irregularities in some of the services rendered by the agency nurses which were not in conformity with the terms set out in the governing contracts," according to DeWare's decision.
No details are provided, but "in order to investigate potential deficiencies in the services rendered by the nursing agencies, [Vitalité] commissioned an internal audit of the performance of one of the contracts spanning the period between August 2022 and June 2023."
Vitalité alleges these audits "confirmed the existence of deficiencies in the performance of the agency nurses' contract with one of the agencies — Canadian Health Labs," DeWare wrote.
The company has since launched three lawsuits against Vitalité for allegedly breaching three of its contracts — two expired and one still in force. It's seeking compensation, including punitive, aggravated and special damages.
Vitalité has filed statements of defence, as well as counterclaims in all three cases.
Martin argued act covers privileged information
Martin applied to the court for an injunction on Oct. 9. "Under the Auditor General Act, I have rights of access to any information relating to the performance of my duties," he wrote in a sworn affidavit. This includes privileged information, he argued.
Section 13 (a) of the act says the auditor general is entitled to "free access at all convenient times to information, including files, documents, records, agreements and contracts, despite that they may be confidential or private, that relates to the fulfilment of his or her responsibilities."
According to Martin, changes the legislature made to that section in 2014, including the auditor general's ability to obtain "private and confidential" information, were specifically made to address this type of situation, DeWare wrote. Discussions surrounding the amendments demonstrate there was a clear desire to enhance the auditor general's authority to obtain necessary information, Martin argued.
Vitalité says disclosure would prejudice litigation
Vitalité countered that disclosure of the internal audit reports "would prejudice its ability to prosecute" the action against Canadian Health Labs, according to Deware, and that Section 13 (a) of the act "does not explicitly displace or supersede otherwise valid claims of litigation or solicitor-client privilege."
If the New Brunswick Legislature had intended for the section to override litigation or solicitor-client privilege, it would have explicitly stated so in the statute, as it does in the Ombudsman Act, Vitalité argued.
DeWare noted the Ontario Court of Appeal recently upheld a trial court decision that the Auditor General Act of that province, which, similar to New Brunswick's, does not contain a specific waiver of a valid privilege, "did not authorize access nor compel disclosure of privileged information."
The Supreme Court of Canada also considered a similar issue when interpreting a section of Alberta's Freedom of Information and Protection of Privacy Act in 2016, said DeWare. The country's highest court ruled legislative language must be interpreted restrictively when determining if solicitor-client privilege may be set aside.
Act not explicit, judge rules
"While I appreciate the [auditor general's] argument, the addition of the words 'confidential and private' to section 13 indicates an expanded scope to the information which could be sought, it falls short of explicitly stating an intention to have access to 'privileged' documents," DeWare said.
She pointed out that with the 2014 amendments, the legislature didn't adopt the "explicit" language of Nova Scotia's Auditor General Act — "solicitor-client privilege, litigation privilege, settlement privilege and public interest immunity."
"The language of the Nova Scotia statute could not be any clearer."
Section 13 (a) of the New Brunswick act "does not grant the Auditor General the authority to require production of documents or information which are properly subject to a solicitor-client or litigation privilege," DeWare ruled.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
11 minutes ago
- Globe and Mail
With a $3.8 Trillion Market Cap, Does Nvidia Really Still Have Room to Grow?
Nvidia (NASDAQ: NVDA) is the largest publicly traded company, with a market cap of about $3.8 trillion on Friday afternoon, and a stock price that's just below its all-time high. Nvidia's growth story has been nothing short of extraordinary. Revenue has grown by nearly 400% over the past two years as AI investment activity has exploded, and that's after an already extremely impressive multidecade history. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » If you don't already own Nvidia, is it too late to invest? With an estimated 95% share of its most important end markets and nearly $150 billion in revenue over the past four quarters, it's easy to understand why Nvidia's upside from here might appear limited. But I'd argue the opposite. Not only do I think Nvidia's revenue could get much larger from here, but the stock could produce market-beating returns for many years to come. Nvidia has more growth potential than you might think Nvidia has four main business segments: data center, gaming, professional visualization, and automotive. The data center segment is by far the most important. In simple terms, AI-focused applications require a tremendous amount of data processing ability, and Nvidia's data center accelerator products are widely considered to be the gold standard. As mentioned, the company has a dominant (estimated) 95% market share. And the industry itself is growing rapidly. Over the past year, Nvidia's data center segment sales tripled, and the $120 billion global market for data center accelerators is expected to roughly double over the next five years. Data center capital spending -- mostly by large tech companies -- is expected to reach $1 trillion annually in just three years, compared to $500 billion today. In other words, if Nvidia simply maintains its dominant market share, the largest and most critical part of its business could double or more in size by 2030. The company's other segments have lots of room to grow as well. The automotive segment is a big opportunity, as advanced autonomous vehicle technology is still in the early stages of evolution, and Nvidia already has 20 of the top 30 EV manufacturers on its customer roster. In fact, GPUs for automotive applications is expected to be a $45 billion market by 2030, and Nvidia also develops software systems, safety systems, and more for automotive applications. Capital allocation and a reasonable valuation Nvidia's free cash flow hasn't been anywhere near the current level for long, but now that the company is generating boatloads of cash, management is allocating it in shareholder-friendly ways. The company does pay a quarterly dividend, but it's a minuscule one (0.03% yield), at least for now. But buybacks are becoming an increasingly large focus of management. In the first quarter, Nvidia spent more than $14 billion on stock buybacks, which was more than half of the company's free cash flow. However, keep in mind that Nvidia's free cash flow grew by 75% year over year, and is expected to grow rapidly for at least the next few years, so it wouldn't be surprising to see buybacks expand along with it. Finally, Nvidia is not a cheap stock, trading at 48 times trailing 12-month earnings and about 34 times sales. But it isn't necessarily an expensive one. Nvidia's revenue growth (both past and projected) clearly justifies a higher P/E ratio. Analyst estimates call for 44% year-over-year earnings growth in the current fiscal year (ending January 2026) and another 34% in the following year. Plus, the combination of this growth rate and Nvidia's stellar margins (net margin over 50%) warrant an elevated price-to-sales multiple. In fact, by some popular metrics, such as the price/earnings-to-growth (PEG) ratio, Nvidia stock looks rather attractive right now. The bottom line is that a combination of a growing market opportunity, shareholder-friendly capital allocation, and a reasonable valuation could allow Nvidia to continue to grow and produce excellent returns for years to come. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor 's total average return is1,062% — a market-crushing outperformance compared to177%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025


CTV News
17 minutes ago
- CTV News
Alcohol to be served on pedal pubs
Ottawa Watch The Ford government's push to make alcohol more accessible is moving forward with pedal pubs getting the green light to serve booze. CTV's Dylan Dyson has the details.


CTV News
17 minutes ago
- CTV News
B.C. nurse suspended 12 months for sexual relationship with client
A B.C. nurse's registration has been suspended for 12 months as discipline for a sexual relationship the worker had with a client, according to the regulatory body. The B.C. College of Nurses and Midwives described the relationship, which happened between July and September of 2023, as 'personal and sexual.' The nurse, who is not named in the consent agreement reached with the college earlier this week due to privacy regulations, 'documented that at the time of the conduct, they suffered from a health condition that was a factor in their conduct,' reads an online summary. 'Intimate' relationships between nurses and clients are prohibited, even if they are consensual, the college said, adding that a breach of professional boundaries can harm the patient. 'The nurse-client relationship is the foundation of nursing practice across all populations and cultures and in all practice settings. It is therapeutic and focuses on the needs of the client. It is based on trust, respect and professional intimacy, and it requires the appropriate use of authority,' the summary reads. According to the college, the nurse agreed to have their registration suspended for 12 months and a six-month ban on working in community nursing. If they return to the job, the nurse will be required to be 'followed by' a counsellor for a year. 'The inquiry committee is satisfied that the terms will address the professional and practice concerns that arose and will protect the public,' the BCCNM wrote.